Eli Lilly's Retatrutide: A Promising New Weight Loss Drug
Eli Lilly's next-generation drug, retatrutide, has demonstrated significant weight loss in a crucial late-stage trial for patients with obes...
BRP: A Natural Alternative:: Stanford scientists have discovered a peptide called BRP that mimics Ozempic's appetite-suppressing effects.
Fewer Side Effects:: Unlike Ozempic, BRP appears to act directly on the brain's appetite-control center, reducing the likelihood of nausea, constipation, and muscle loss.
AI-Driven Discovery:: Artificial intelligence was instrumental in identifying BRP by sifting through thousands of molecules.
Targeted Action:: BRP selectively targets the hypothalamus, which controls appetite and metabolism, unlike Ozempic, which affects multiple tissues.
Indian BMI Considerations:: Semaglutide guidelines based on BMI may exclude at-risk Indians, as they develop cardiovascular disease at lower body weights, according to experts from The Hindu.
Semaglutide drugs like Ozempic have become popular for weight loss, but their side effects and broad action across various tissues have raised concerns. The discovery of BRP offers a potentially more refined approach.
BRP (BRINP2-related peptide) is a small peptide comprising only 12 amino acids. It was identified using a computer tool called Peptide Predictor, which scanned 20,000 human protein-coding genes. Animal studies have shown that BRP reduces food intake and body weight, primarily from fat loss, without significant side effects.
The targeted action of BRP in the hypothalamus could provide a safer and more effective weight loss solution. This is particularly relevant for populations like Indians, where standard BMI guidelines may not accurately reflect cardiovascular risk.
While BRP is still in early stages of research, its discovery highlights the potential for AI-driven drug discovery and more targeted therapies for obesity.
Q: What is BRP?
BRP (BRINP2-related peptide) is a naturally occurring molecule discovered by Stanford scientists that mimics the weight loss effects of Ozempic.
Q: How does BRP differ from Ozempic?
BRP appears to act specifically in the hypothalamus, controlling appetite and metabolism, whereas Ozempic has widespread effects due to targeting receptors in the gut, pancreas, and other tissues.
Q: Are there human trials for BRP?
A company co-founded by one of the lead researchers plans to begin human clinical trials in the near future.
BRP offers a promising natural alternative to Ozempic with potentially fewer side effects.
The discovery underscores the power of AI in identifying novel therapeutic molecules.
Current BMI guidelines for semaglutide eligibility may not be appropriate for all populations, particularly in India.
Do you think BRP will revolutionize weight loss treatments? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Eli Lilly's next-generation drug, retatrutide, has demonstrated significant weight loss in a crucial late-stage trial for patients with obes...
Staying healthy involves consistent effort and the journey looks different for everyone. Jillian Michaels and Megyn Kelly have recently shar...
The market for weight-loss drugs is heating up as Novo Nordisk, the maker of Wegovy, takes legal action against telehealth companies like Hi...
Oprah Winfrey has openly discussed her decades-long battle with weight, and a recent epiphany has shifted her perspective. She now views obe...
⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer